Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin during labor for maternal and neonatal infections
NCT06958146Phase 4Not yet recruiting
- Sponsor
- Combined Military Hospital
- Start
- May 2025
- Primary completion
- Aug 2025
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of azithromycin in maternal sepsis and neonatal sepsis (2 arms), sponsored by Combined Military Hospital. Primary endpoint: Maternal infections. Planned start May 2025; status: not yet recruiting.
02
Drugs
azithromycin
03
Conditions
maternal sepsisneonatal sepsis
Beyond the preview
Go deeper on NCT06958146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06958146.